Found 130 matching trials
Iressa Expanded Access Program (EAP)
PHASE3A program for patients with non small cell lung cancer who may benefit from...
VX-770 Expanded Access Program
N/AThe purpose of this expanded access program is to provide VX-770 prior to i...
Status
Approved For Marketing
Location
Multiple Locations
89Zr-DFO-girentuximab Expanded Access Program (EAP)
N/AThe purpose of this Expanded Access Program (EAP) is to enable the use of 8...
Status
No Longer Available
A Study of Complement 3 Glomerulopathy (C3G) Patients Treated With Iptacopan Through an Early Access Program in Spain
N/AThis study aims to characterize the patient profiles and the clinical exper...
Location
Multiple Locations
EAP for Deucrictibant Immediate-release
N/AThis is an expanded access program (EAP) designed to allow access to deucri...
Location
Multiple Locations
Intermediate-Size Expanded Access Protocol (EAP) for LP352
N/AThis is an intermediate-size expanded access program (EAP) study. The purpo...
Location
Rancho Research Institute
Observations From Long Term Responders in the Gefitinib (Iressa) Expanded Access Program (EAP)
N/AThe purpose of the study is to determine patient characteristics from patie...
Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel
N/AThe purpose of this expanded access protocol (EAP) is to provide controlled...
Expanded Access Program for Epcoritamab
N/AThe purpose of this program is to provide investigational epcoritamab, an a...
Status
Approved For Marketing
Location
Multiple Locations
Expanded Access Program for Idebenone in Participants With Duchenne Muscular Dystrophy (DMD)
N/AThe primary objective of this Expanded Access Program is to provide idebeno...
Status
No Longer Available
Location
Phoenix Children's Hospital